FIELD: medicine.
SUBSTANCE: invention refers to medicine, namely to narcology, and can be used for rehabilitation of patients with alcoholism in abstinence syndrome. For this purpose, pharmacotherapy is added with administration of Galodif 100 mg 3 times a day by the therapeutic course 21 days.
EFFECT: method allows ensuring a stable therapeutic effect expressed in lower intensity of morbid attraction to alcohol in the presence of a various degree of intensity of affective disorders due to normothymoleptic, analgesic and vegetostabilising effects.
2 ex, 8 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| AGENT DECREASING ALCOHOLIC MOTIVATION | 1999 |
|
RU2155034C1 |
| METHOD FOR TREATING POST-ABSTINENT STATES IN CASE OF ALCOHOLISM | 2005 |
|
RU2304970C2 |
| METHOD FOR ALLEVIATING COMPLICATED ABSTINENCE SYNDROME | 1992 |
|
RU2067442C1 |
| AGENT EXHIBITING WITH DETOXIFYING ACTIVITY IN ALCOHOL INTOXICATION | 2021 |
|
RU2787997C1 |
| METHOD FOR MAKING ALCOHOLISM PATIENT REHABILITATION AT REMISSION CREATION STAGE | 2006 |
|
RU2318512C1 |
| METHOD OF TREATING WITHDRAWAL SYNDROME IN ALCOHOLISM | 2019 |
|
RU2726465C1 |
| PHARMACEUTICAL PREPARATION SHOWING ANTIALCOHOLIC AND NOOTROPIC EFFECTS | 1995 |
|
RU2097034C1 |
| AGENT FOR ALCOHOLIC ABSINENT SYNDROME ARRESTING | 2000 |
|
RU2167655C1 |
| METHOD FOR TREATMENT OF AFFECTIVE DISORDERS SELECTED FROM MANIC-DEPRESSIVE PSYCHOSIS, CYCLOTHYMIA, SCHIZOAFFECTIVE PSYCHOSIS AND CAUSED BY EXCESSIVE ALCOHOL CONSUMPTION | 2021 |
|
RU2791700C2 |
| METHOD FOR PREDICTION OF CLINICAL EFFECTIVENESS IN SCHIZOPHRENIC PATIENTS | 2014 |
|
RU2546021C1 |
